PDB34 LOWER LONG-TERM COSTS IN GERMAN TYPE-2-DIABETICS STARTING A BASAL SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE COMPARED TO NPH-INSULIN
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75012-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)75012-9/fulltext
Title :
PDB34 LOWER LONG-TERM COSTS IN GERMAN TYPE-2-DIABETICS STARTING A BASAL SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE COMPARED TO NPH-INSULIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75012-9&doi=10.1016/S1098-3015(10)75012-9
First page :
Section Title :
Open access? :
No
Section Order :
937